MYASTHENIA GRAVIS
Clinical trials for MYASTHENIA GRAVIS explained in plain language.
Never miss a new study
Get alerted when new MYASTHENIA GRAVIS trials appear
Sign up with your email to follow new studies for MYASTHENIA GRAVIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Myasthenia gravis drug trial halted early – only 6 patients enrolled
Disease control TerminatedThis study tested tolebrutinib, an oral drug, in adults with moderate-to-severe generalized myasthenia gravis. The trial was a Phase 3, double-blind, placebo-controlled study that planned to enroll many participants but was terminated early with only 6 people enrolled. Because it…
Matched conditions: MYASTHENIA GRAVIS
Phase: PHASE3 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 26, 2026 14:27 UTC
-
Abandoned trial: only 2 patients tested for stomach relief in muscle disease
Symptom relief TerminatedThis small, early-stage trial tested whether adding ondansetron (an anti-nausea drug) to pyridostigmine (a standard myasthenia gravis treatment) could reduce stomach side effects like nausea, vomiting, or diarrhea. Only 2 people with anti-AchR positive myasthenia gravis were enro…
Matched conditions: MYASTHENIA GRAVIS
Phase: PHASE2 • Sponsor: DAS-MG, Inc • Aim: Symptom relief
Last updated Jun 26, 2026 15:47 UTC